The most favorable analytical condition to measure MV-associated thrombin generation in patients with pancreatic cancer and healthy controls was to add the isolated MVs into low contact-activated PNP without CTI and without external phospholipids, but in the presence of anti-TFPI antibodies. This evidence concerns the gene TFPI and pancreatic neoplasm.